Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

BACKGROUND: S1400D is a biomarker-driven therapeutic sub-study of Lung-MAP evaluating the fibroblast growth factor receptor (FGFR) inhibitor AZD4547 in patients with FGF pathway-activated squamous cell non-small cell lung cancer (SqNSCLC). This is the first phase II trial to evaluate AZD4547 as a ta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Oncol
Hlavní autoři: Aggarwal, Charu, Redman, Mary W., Lara, Primo N., Borghaei, Hossein, Hoffman, Philip, Bradley, Jeffrey D., Newman, Alfred J., Feldman, Marvin J., Minichiello, Katherine, Miao, Jieling, Mack, Philip C., Papadimitrakopoulou, Vassiliki A., Herbst, Roy S., Kelly, Karen, Gandara, David R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6901020/
https://ncbi.nlm.nih.gov/pubmed/31195180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.05.041
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky